Bartel, D. P. Metazoan microRNAs. Cell 173(1), 20–51 (2018).
Uhlmann, S. et al. Global microRNA level regulation of EGFR-driven cell-cycle protein network in breast cancer. Mol. Syst. Biol. 8, 570 (2012).
Friedman, R. C. et al. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19(1), 92–105 (2009).
Girardi, E., López, P. & Pfeffer, S. On the importance of host MicroRNAs during viral infection. Front. Genet. 9, 439 (2018).
Siniscalchi, C. et al. Human MicroRNAs interacting with SARS-CoV-2 RNA sequences: Computational analysis and experimental target validation. Front. Genet. 12, 678994 (2021).
Akula, S. M., Bolin, P. & Cook, P. P. Cellular miR-150-5p may have a crucial role to play in the biology of SARS-CoV-2 infection by regulating nsp10 gene. RNA Biol. 19(1), 1–11 (2022).
Trobaugh, D. W. & Klimstra, W. B. MicroRNA regulation of RNA virus replication and pathogenesis. Trends Mol. Med. 23(1), 80–93 (2017).
Leon-Icaza, S. A., Zeng, M. & Rosas-Taraco, A. G. microRNAs in viral acute respiratory infections: Immune regulation, biomarkers, therapy, and vaccines. ExRNA 1(1), 1 (2019).
Zou, L. et al. The SARS-CoV-2 protein NSP2 impairs the silencing capacity of the human 4EHP-GIGYF2 complex. iScience 25(7), 104646 (2022).
Trobaugh, D. W. et al. RNA viruses can hijack vertebrate microRNAs to suppress innate immunity. Nature 506(7487), 245–248 (2014).
Li, C. et al. SARS-COV-2 as potential microRNA sponge in COVID-19 patients. BMC Med. Genom. 15(2), 94 (2022).
Bartoszewski, R. et al. SARS-CoV-2 may regulate cellular responses through depletion of specific host miRNAs. Am. J. Physiol. Lung Cell. Mol. Physiol. 319(3), L444-l455 (2020).
Qiao, Y. et al. Epstein-Barr virus circRNAome as host miRNA sponge regulates virus infection, cell cycle, and oncogenesis. Bioengineered 10(1), 593–603 (2019).
Cazalla, D. & Steitz, J. A. Down-regulation of a host microRNA by a viral noncoding RNA. Cold Spring Harb. Symp. Quant. Biol. 75, 321–324 (2010).
Luna, J. M. et al. Hepatitis C virus RNA functionally sequesters miR-122. Cell 160(6), 1099–1110 (2015).
Mitchell, P. S. et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. USA 105(30), 10513–10518 (2008).
Pawlica, P. et al. SARS-CoV-2 expresses a microRNA-like small RNA able to selectively repress host genes. Proc. Natl. Acad. Sci. USA 118(52), e2116668118 (2021).
Singh, M. et al. A virus-derived microRNA targets immune response genes during SARS-CoV-2 infection. EMBO Rep. 23(2), e54341 (2022).
Morales, L. et al. SARS-CoV-encoded small RNAs contribute to infection-associated lung pathology. Cell Host Microbe 21(3), 344–355 (2017).
Tribolet, L. et al. MicroRNA biomarkers for infectious diseases: From basic research to biosensing. Front. Microbiol. 11, 1197 (2020).
Fu, Z. et al. A virus-derived microRNA-like small RNA serves as a serum biomarker to prioritize the COVID-19 patients at high risk of developing severe disease. Cell Discov. 7(1), 48 (2021).
Grehl, C. et al. Detection of SARS-CoV-2 derived small RNAs and changes in circulating small RNAs associated with COVID-19. Viruses 13(8), 1593 (2021).
Meng, F. et al. Viral MicroRNAs encoded by nucleocapsid gene of SARS-CoV-2 are detected during infection, and targeting metabolic pathways in host cells. Cells 10(7), 1762 (2021).
Farr, R. J. et al. Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection. PLoS Pathog. 17(7), e1009759 (2021).
McDonald, J. T. et al. Role of miR-2392 in driving SARS-CoV-2 infection. Cell Rep. 37(3), 109839 (2021).
Li, C. et al. Differential microRNA expression in the peripheral blood from human patients with COVID-19. J. Clin. Lab. Anal. 34(10), e23590 (2020).
Garg, A. et al. Circulating cardiovascular microRNAs in critically ill COVID-19 patients. Eur. J. Heart Fail. 23(3), 468–475 (2021).
Tang, H. et al. The noncoding and coding transcriptional landscape of the peripheral immune response in patients with COVID-19. Clin. Transl. Med. 10(6), e200 (2020).
Saulle, I. et al. MiRNA profiling in plasma and placenta of SARS-CoV-2-infected pregnant women. Cells 10(7), 1788 (2021).
Wang, Y. et al. Decreased inhibition of exosomal miRNAs on SARS-CoV-2 replication underlies poor outcomes in elderly people and diabetic patients. Signal Transduct. Target Ther. 6(1), 300 (2021).
Park, J. H. et al. Potential therapeutic effect of micrornas in extracellular vesicles from mesenchymal stem cells against SARS-CoV-2. Cells 10(9), 2393 (2021).
Sabbatinelli, J. et al. Decreased serum levels of the inflammaging marker miR-146a are associated with clinical non-response to tocilizumab in COVID-19 patients. Mech. Ageing Dev. 193, 111413 (2021).
Centa, A. et al. Deregulated miRNA expression is associated with endothelial dysfunction in post-mortem lung biopsies of COVID-19 patients. Am. J. Physiol. Lung Cell Mol. Physiol. 320(3), L405–L412 (2020).
Fayyad-Kazan, M. et al. Circulating miRNAs: Potential diagnostic role for coronavirus disease 2019 (COVID-19). Infect. Genet. Evol. 94, 105020 (2021).
Bagheri-Hosseinabadi, Z. et al. The relationship between serum levels of interleukin-2 and IL-8 with circulating microRNA-10b in patients with COVID-19. Iran. J. Immunol. 18(1), 65–73 (2021).
Li, C. X. et al. Whole-transcriptome RNA sequencing reveals significant differentially expressed mRNAs, miRNAs, and lncRNAs and related regulating biological pathways in the peripheral blood of COVID-19 patients. Mediators Inflamm. 2021, 6635925 (2021).
Keikha, R., Hashemi-Shahri, S. M. & Jebali, A. The relative expression of miR-31, miR-29, miR-126, and miR-17 and their mRNA targets in the serum of COVID-19 patients with different grades during hospitalization. Eur. J. Med. Res. 26(1), 75 (2021).
Pimenta, R. et al. MiR-200c-3p expression may be associated with worsening of the clinical course of patients with COVID-19. Mol. Biol. Res. Commun. 10(3), 141–147 (2021).
Donyavi, T. et al. Acute and post-acute phase of COVID-19: Analyzing expression patterns of miRNA-29a-3p, 146a–3p, 155–5p, and let-7b-3p in PBMC. Int. Immunopharmacol. 97, 107641 (2021).
Kassif-Lerner, R. et al. miR-155: A potential biomarker for predicting mortality in COVID-19 patients. J. Pers. Med. 12(2), 324 (2022).
Linsley, P. S. et al. Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression. Mol. Cell. Biol. 27(6), 2240–2252 (2007).
Bandi, N. et al. miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. Cancer Res. 69(13), 5553–5559 (2009).
Devadas, K. et al. Identification of host micro RNAs that differentiate HIV-1 and HIV-2 infection using genome expression profiling techniques. Viruses 8(5), 121 (2016).
Biswas, S. et al. Development and validation of plasma miRNA biomarker signature panel for the detection of early HIV-1 infection. EBioMedicine 43, 307–316 (2019).
Zhu, X. et al. MicroRNA-195 suppresses enterovirus A71-induced pyroptosis in human neuroblastoma cells through targeting NLRX1. Virus Res. 292, 198245 (2021).
Chow, J. T. & Salmena, L. Prediction and analysis of SARS-CoV-2-targeting MicroRNA in human lung epithelium. Genes (Basel) 11(9), 1002 (2020).
Blanco-Melo, D. et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell 181(5), 1036-1045.e9 (2020).
Kgatle, M. M. et al. COVID-19 is a multi-organ aggressor: Epigenetic and clinical marks. Front. Immunol. 12, 752380 (2021).
Zhang, X. & Schulze, P. C. MicroRNAs in heart failure: Non-coding regulators of metabolic function. Biochim. Biophys. Acta 1862(12), 2276–2287 (2016).
Long, G. et al. Circulating miR-30a, miR-195 and let-7b associated with acute myocardial infarction. PLoS ONE 7(12), e50926 (2012).
Zheng, D. et al. Inhibition of MicroRNA 195 prevents apoptosis and multiple-organ injury in mouse models of sepsis. J. Infect. Dis. 213(10), 1661–1670 (2016).
Cheng, H. Y. et al. miR-195 has a potential to treat ischemic and hemorrhagic stroke through neurovascular protection and neurogenesis. Mol. Ther. Methods Clin. Dev. 13, 121–132 (2019).
Xu, Y. et al. miR-195-5p alleviates acute kidney injury through repression of inflammation and oxidative stress by targeting vascular endothelial growth factor A. Aging (Albany NY) 12(11), 10235–10245 (2020).
Qin, J.-Z., Wang, S.-J. & Xia, C. microRNAs regulate nitric oxide release from endothelial cells by targeting NOS3. J. Thromb. Thrombolysis 46(3), 275–282 (2018).
Gasparello, J., Finotti, A. & Gambari, R. Tackling the COVID-19 “cytokine storm” with microRNA mimics directly targeting the 3’UTR of pro-inflammatory mRNAs. Med. Hypotheses 146, 110415 (2021).
Park, J. et al. System-wide transcriptome damage and tissue identity loss in COVID-19 patients. Cell. Rep. Med. 3(2), 100522 (2022).
Berlin, D. A., Gulick, R. M. & Martinez, F. J. Severe Covid-19. N. Engl. J. Med. 383(25), 2451–2460 (2020).
de Bruin, S. et al. Clinical features and prognostic factors in Covid-19: A prospective cohort study. EBioMedicine 67, 103378 (2021).
Yang, A. P. et al. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int. Immunopharmacol. 84, 106504 (2020).
Yekelchyk, M. et al. Flower lose, a cell fitness marker, predicts COVID-19 prognosis. EMBO Mol. Med. 13(11), e13714 (2021).
de Gonzalo-Calvo, D. et al. Circulating microRNA profiles predict the severity of COVID-19 in hospitalized patients. Transl. Res. 236, 147–159 (2021).
Gutmann, C. et al. Association of cardiometabolic microRNAs with COVID-19 severity and mortality. Cardiovasc. Res. 118(2), 461–474 (2022).
Parray, A. et al. SnoRNAs and miRNAs networks underlying COVID-19 disease severity. Vaccines (Basel) 9(10), 1056 (2021).
Giuliani, A. et al. Circulating miR-320b and miR-483-5p levels are associated with COVID-19 in-hospital mortality. Mech. Ageing Dev. 202, 111636 (2022).
Fernández-Pato, A. et al. Plasma miRNA profile at COVID-19 onset predicts severity status and mortality. Emerg. Microbes Infect. 11(1), 676–688 (2022).
Gustafson, D. et al. Cardiovascular signatures of COVID-19 predict mortality and identify barrier stabilizing therapies. EBioMedicine 78, 103982 (2022).
Wiersinga, W. J. et al. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): A review. JAMA 324(8), 782–793 (2020).
Hogan, C. A. et al. High frequency of SARS-CoV-2 RNAemia and association with severe disease. Clin. Infect. Dis. 72(9), e291–e295 (2021).
Tang, K. et al. Quantitative assessment of SARS-CoV-2 RNAemia and outcome in patients with coronavirus disease 2019. J. Med. Virol. 93(5), 3165–3175 (2021).
Ram-Mohan, N. et al. SARS-CoV-2 RNAemia predicts clinical deterioration and extrapulmonary complications from COVID-19. Clin. Infect. Dis. 74(2), 218–226 (2022).
Chen, X. et al. Detectable serum severe acute respiratory syndrome coronavirus 2 viral load (RNAemia) is closely correlated with drastically elevated interleukin 6 level in critically ill patients with coronavirus disease 2019. Clin. Infect. Dis. 71(8), 1937–1942 (2020).
Olea, B. et al. Lower respiratory tract and plasma SARS-CoV-2 RNA load in critically ill adult COVID-19 patients: Relationship with biomarkers of disease severity. J. Infect. 83(3), 381–412 (2021).
Gutmann, C. et al. SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care. Nat. Commun. 12(1), 3406 (2021).
Costa, R. et al. Combined kinetic analysis of SARS-CoV-2 RNAemia, N-antigenemia and virus-specific antibodies in critically ill adult COVID-19 patients. Sci. Rep. 12(1), 8273 (2022).
Xu, D. et al. Relationship between serum severe acute respiratory syndrome coronavirus 2 nucleic acid and organ damage in coronavirus 2019 patients: A cohort study. Clin. Infect. Dis. 73(1), 68–75 (2021).
Nersisyan, S. et al. Potential role of cellular miRNAs in coronavirus-host interplay. PeerJ 8, e9994 (2020).
Kim, W. R. et al. Expression analyses of MicroRNAs in hamster lung tissues infected by SARS-CoV-2. Mol. Cells 43(11), 953–963 (2020).
Pepe, G. et al. Evaluation of potential miRNA sponge effects of SARS genomes in human. Noncoding RNA Res. 7(1), 48–53 (2022).
Zhang, Z. et al. microRNA arm-imbalance in part from complementary targets mediated decay promotes gastric cancer progression. Nat. Commun. 10(1), 4397 (2019).
Zhang, S. et al. The miRNA: A small but powerful RNA for COVID-19. Brief Bioinform. 22(2), 1137–1149 (2021).
Shah, A. S. V. et al. Clinical burden, risk factor impact and outcomes following myocardial infarction and stroke: A 25-year individual patient level linkage study. Lancet Reg. Health Eur. 7, 100141 (2021).
Gebert, M. et al. PIWI proteins contribute to apoptosis during the UPR in human airway epithelial cells. Sci. Rep. 8(1), 16431 (2018).
Fung, T. S. & Liu, D. X. Coronavirus infection, ER stress, apoptosis and innate immunity. Front. Microbiol. 5, 296 (2014).
Garnier, N. et al. Altered microRNA expression in severe COVID-19: Potential prognostic and pathophysiological role. Clin. Transl. Med. 12(6), e899 (2022).
Yang, J., Chen, T. & Zhou, Y. Mediators of SARS-CoV-2 entry are preferentially enriched in cardiomyocytes. Hereditas 158(1), 4 (2021).
Singh, K. K. et al. Decoding SARS-CoV-2 hijacking of host mitochondria in COVID-19 pathogenesis. Am. J. Physiol. Cell. Physiol. 319(2), C258-c267 (2020).
Elesela, S. & Lukacs, N. W. Role of mitochondria in viral infections. Life (Basel) 11(3), 232 (2021).
Shang, C. et al. SARS-CoV-2 causes mitochondrial dysfunction and mitophagy impairment. Front. Microbiol. 12, 780768 (2021).
Ramachandran, K. et al. SARS-CoV-2 infection enhances mitochondrial PTP complex activity to perturb cardiac energetics. iScience 25(1), 103722 (2022).
Purohit, P. K. et al. MiR-195 regulates mitochondrial function by targeting mitofusin-2 in breast cancer cells. RNA Biol. 16(7), 918–929 (2019).
Singh, R. et al. MicroRNA-195 inhibits proliferation, invasion and metastasis in breast cancer cells by targeting FASN, HMGCR, ACACA and CYP27B1. Sci. Rep. 5(1), 17454 (2015).
Zhang, R. et al. MiR-195 dependent roles of mitofusin2 in the mitochondrial dysfunction of hippocampal neurons in SAMP8 mice. Brain Res. 1652, 135–143 (2016).
Nishi, H. et al. MicroRNA-15b modulates cellular ATP levels and degenerates mitochondria via Arl2 in neonatal rat cardiac myocytes. J. Biol. Chem. 285(7), 4920–4930 (2010).
Saleh, J. et al. Mitochondria and microbiota dysfunction in COVID-19 pathogenesis. Mitochondrion 54, 1–7 (2020).
Shah, A. Novel coronavirus-induced NLRP3 inflammasome activation: A potential drug target in the treatment of COVID-19. Front. Immunol. 11, 1021 (2020).
Burtscher, J., Millet, G. P. & Burtscher, M. Low cardiorespiratory and mitochondrial fitness as risk factors in viral infections: Implications for COVID-19. Br. J. Sports Med. 55(8), 413–415 (2021).
Xia, H. et al. MiR-195-5p represses inflammation, apoptosis, oxidative stress, and endoplasmic reticulum stress in sepsis-induced myocardial injury by targeting activating transcription factor 6. Cell. Biol. Int. 46(2), 243–254 (2022).
Tomas, C. et al. Cellular bioenergetics is impaired in patients with chronic fatigue syndrome. PLoS ONE 12(10), e0186802 (2017).
Armstrong, C. W. et al. Metabolic profiling reveals anomalous energy metabolism and oxidative stress pathways in chronic fatigue syndrome patients. Metabolomics 11(6), 1626–1639 (2015).
Sweetman, E. et al. A SWATH-MS analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome peripheral blood mononuclear cell proteomes reveals mitochondrial dysfunction. J. Transl. Med. 18(1), 365 (2020).
de Boer, E. et al. Decreased fatty acid oxidation and altered lactate production during exercise in patients with post-acute COVID-19 syndrome. Am. J. Respir. Crit. Care Med. 205(1), 126–129 (2022).
Singh, I. et al. Persistent exertional intolerance after COVID-19: Insights from invasive cardiopulmonary exercise testing. Chest 161(1), 54–63 (2022).
Su, Y. et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell 185(5), 881-895.e20 (2022).
Perez-Bermejo, J. A. et al. SARS-CoV-2 infection of human iPSC-derived cardiac cells reflects cytopathic features in hearts of patients with COVID-19. Sci. Transl. Med. 13(590), eabf7872 (2021).
Pfaffl, M. W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29(9), e45 (2001).
Sticht, C. et al. miRWalk: An online resource for prediction of microRNA binding sites. PLoS ONE 13(10), e0206239 (2018).
Szklarczyk, D. et al. STRING v11: Protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47(D1), D607-d613 (2019).